Related Experiment Video
Updated: Apr 19, 2026

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Ascending paralysis associated with HIV infection
Aasim Afzal1, Mina Benjamin1, Kyle L Gummelt1
1Department of Internal Medicine (Afzal, Benjamin, Gummelt), the Division of Neurology (Shamim), and the Division of Infectious Diseases (Tribble), Baylor University Medical Center at Dallas.
Two HIV-1 patients developed paralysis and respiratory failure. Treatments varied, with one improving on highly active antiretroviral therapy (HAART) and another on intravenous immunoglobulin, suggesting different disease mechanisms.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) infection can manifest with neurological complications.
- Peripheral neuropathies are a known complication of HIV-1, with diverse underlying mechanisms.
Observation:
- Two patients with high HIV-1 viral loads presented with ascending paralysis, respiratory failure, and autonomic instability.
- One patient showed symptom improvement with highly active antiretroviral therapy (HAART) and a reduction in viral load.
- The second patient improved with intravenous immunoglobulin (IVIg) therapy, with limited response to HAART alone.
Findings:
- The differential response to HAART and IVIg suggests distinct pathophysiological pathways for HIV-1-associated neuropathies.
- Potential mechanisms include direct neurotoxicity from HIV-1 or autoimmune processes targeting nerve components.
Implications:
- Understanding the specific pathophysiology is crucial for tailoring effective treatment strategies in HIV-1-neuropathy.
- This case comparison underscores the need for individualized therapeutic approaches based on distinct patient presentations and responses.
Related Concept Videos
Arboviral Encephalitis
Secondary Spinal Cord Injury llI: Pathophysiology
Sexually Transmitted Infections
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Encephalitis l: Introduction

